Stocks · News reference
8-K filing — PDS Biotechnology Corp (PDSB)
Filed: 2026-09-08 AccNo: 0001140361-26-035853 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August
U.S. stocks fell Tuesday, led by a 450-point Dow drop; health care slid while energy rose. NFIB optimism weakened, oil and copper gained.
PDS Biotechnology shares are trading higher after the company announced it raised up to $22.55 million in equity funding in a Private Investment in Public Equity transaction.